Comparative study to examine the effects of changing between thienopyridine drugs on platelet aggregation activity for patients who are consistently treated with dual antiplatelet therapy: DAPT (clopidogrel + aspirin) over 52 weeks - Comparison of novel antiplatelet agent prasugrel versus clopidogrel in Japanese patients who are consistently treated with DAPT (CONVERT 2)

Kurume University Hospital0 个研究点目标入组 150 人开始时间: 2017年5月8日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1)Patients with bleeding tendency or diathesis thereof 2)Patients with severe hepatic impairment 3)Patients with severe renal impairment 4)Patients with poorly controlled blood pressure receiving antihypertensive therapy. 5)Patients with a history of cerebral infarction or transient ischemic attack 6)Patients with a history of hypersensitivity to thienopyridine drugs such as ticlopidine, prasugrel, clopidogrel. 7)Female who are pregnant, suspected to pregnant, wish to be pregnant, or lactating. 8)Patients who are mentally incompetent (including moderate or serious dementia) and not to gain understanding and cooperation judged by Investigator 9)Patients who are hospitalized during the observation period, or needs to be hospitalized during the research period judged by Investigator. 10)Patients who need to receive treatment with prohibited concomitant drugs during the study 11)Patients disqualified from participation in the study by the principal investigator or study investigators

发起方